Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers?
Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? have?
Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? has 12 citations in the OpenAlex counts ScholarIQ stores.
When was Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? published?
Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? has 2018 year in the ScholarIQ index.
What is the open-access status of Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers??
Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? has closed oa status in the ScholarIQ index.
What is the DOI of Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers??
The DOI for Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? is on the source record.
What is the PMID of Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers??
The PMID for Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? is on the source record.
What is the OpenAlex record for Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers??
The OpenAlex for Con: Tolvaptan for autosomal dominant polycystic kidney disease—do we know all the answers? is on the source record.